Cargando…

Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures

The mortality-to-incidence ratio (MIR) is widely used to evaluate the efficacy of cancer management outcomes for individual countries. However, the association among health care expenditure, human development index (HDI), and changes in MIR over time (δMIR) remains unknown. We aimed to elucidate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tzu-Wei, Wang, Chi-Chih, Hung, Wei-Cheng, Liu, Yu-Hsiang, Sung, Wen-Wei, Tsai, Ming-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415830/
https://www.ncbi.nlm.nih.gov/pubmed/34485236
http://dx.doi.org/10.3389/fpubh.2021.713895
_version_ 1783748044497354752
author Yang, Tzu-Wei
Wang, Chi-Chih
Hung, Wei-Cheng
Liu, Yu-Hsiang
Sung, Wen-Wei
Tsai, Ming-Chang
author_facet Yang, Tzu-Wei
Wang, Chi-Chih
Hung, Wei-Cheng
Liu, Yu-Hsiang
Sung, Wen-Wei
Tsai, Ming-Chang
author_sort Yang, Tzu-Wei
collection PubMed
description The mortality-to-incidence ratio (MIR) is widely used to evaluate the efficacy of cancer management outcomes for individual countries. However, the association among health care expenditure, human development index (HDI), and changes in MIR over time (δMIR) remains unknown. We aimed to elucidate the significance between these indicators and gastric cancer outcomes in different countries. Among the regions, Asia had the highest number of new gastric cancer cases, gastric cancer-related deaths, age-standardized ratio of incidence, and mortality. Chile had the highest age-standardized ratio (ASR) for gastric cancer incidence and the highest ASR for mortality. Moreover, MIR was highest in Africa (0.91) and lowest in North America (0.43). Of note, MIR was negatively associated with HDI, current health expenditure (CHE) per capita, and CHE/GDP % and δMIR was positively associated with CHE/GDP % in countries with very high HDI. However, δMIR showed no significant associations with these indicators in the countries analyzed. In conclusion, increased HDI, CHE per capita, and CHE/GDP are associated with improved gastric cancer outcomes. In addition, the δMIR could be an indicator that can be used to evaluate the improvement in cancer management outcomes over time.
format Online
Article
Text
id pubmed-8415830
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84158302021-09-04 Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures Yang, Tzu-Wei Wang, Chi-Chih Hung, Wei-Cheng Liu, Yu-Hsiang Sung, Wen-Wei Tsai, Ming-Chang Front Public Health Public Health The mortality-to-incidence ratio (MIR) is widely used to evaluate the efficacy of cancer management outcomes for individual countries. However, the association among health care expenditure, human development index (HDI), and changes in MIR over time (δMIR) remains unknown. We aimed to elucidate the significance between these indicators and gastric cancer outcomes in different countries. Among the regions, Asia had the highest number of new gastric cancer cases, gastric cancer-related deaths, age-standardized ratio of incidence, and mortality. Chile had the highest age-standardized ratio (ASR) for gastric cancer incidence and the highest ASR for mortality. Moreover, MIR was highest in Africa (0.91) and lowest in North America (0.43). Of note, MIR was negatively associated with HDI, current health expenditure (CHE) per capita, and CHE/GDP % and δMIR was positively associated with CHE/GDP % in countries with very high HDI. However, δMIR showed no significant associations with these indicators in the countries analyzed. In conclusion, increased HDI, CHE per capita, and CHE/GDP are associated with improved gastric cancer outcomes. In addition, the δMIR could be an indicator that can be used to evaluate the improvement in cancer management outcomes over time. Frontiers Media S.A. 2021-08-17 /pmc/articles/PMC8415830/ /pubmed/34485236 http://dx.doi.org/10.3389/fpubh.2021.713895 Text en Copyright © 2021 Yang, Wang, Hung, Liu, Sung and Tsai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Yang, Tzu-Wei
Wang, Chi-Chih
Hung, Wei-Cheng
Liu, Yu-Hsiang
Sung, Wen-Wei
Tsai, Ming-Chang
Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
title Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
title_full Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
title_fullStr Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
title_full_unstemmed Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
title_short Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
title_sort improvement in the mortality-to-incidence ratios for gastric cancer in developed countries with high health expenditures
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415830/
https://www.ncbi.nlm.nih.gov/pubmed/34485236
http://dx.doi.org/10.3389/fpubh.2021.713895
work_keys_str_mv AT yangtzuwei improvementinthemortalitytoincidenceratiosforgastriccancerindevelopedcountrieswithhighhealthexpenditures
AT wangchichih improvementinthemortalitytoincidenceratiosforgastriccancerindevelopedcountrieswithhighhealthexpenditures
AT hungweicheng improvementinthemortalitytoincidenceratiosforgastriccancerindevelopedcountrieswithhighhealthexpenditures
AT liuyuhsiang improvementinthemortalitytoincidenceratiosforgastriccancerindevelopedcountrieswithhighhealthexpenditures
AT sungwenwei improvementinthemortalitytoincidenceratiosforgastriccancerindevelopedcountrieswithhighhealthexpenditures
AT tsaimingchang improvementinthemortalitytoincidenceratiosforgastriccancerindevelopedcountrieswithhighhealthexpenditures